Variant report
Variant | esv1847603 |
---|---|
Chromosome Location | chr17:16710840-16720741 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:77)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr17:16719169-16719457 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr17:16719341-16719384 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BATF | chr17:16710949-16711369 | GM12878 | blood: | n/a | chr17:16711188-16711198 chr17:16711187-16711198 |
4 | BATF | chr17:16711019-16711268 | GM12878 | blood: | n/a | chr17:16711188-16711198 chr17:16711187-16711198 |
5 | CTCF | chr17:16719216-16719498 | NHEK | skin: | n/a | n/a |
6 | CTCF | chr17:16718040-16718190 | WERI-Rb-1 | eye: | n/a | n/a |
7 | CTCF | chr17:16719240-16719390 | HMEC | breast: | n/a | n/a |
8 | CTCF | chr17:16719334-16719455 | Pancreas_OC | pancreas: | n/a | n/a |
9 | CTCF | chr17:16713824-16713893 | GM13976 | blood: | n/a | n/a |
10 | CTCF | chr17:16719553-16719585 | Kidney_OC | kidney: | n/a | n/a |
11 | CTCF | chr17:16719220-16719370 | SAEC | small airway: | n/a | n/a |
12 | CTCF | chr17:16719394-16719507 | LNCaP | prostate: | n/a | n/a |
13 | CTCF | chr17:16714100-16714250 | NB4 | blood: | n/a | n/a |
14 | CTCF | chr17:16716458-16716534 | GM13976 | blood: | n/a | n/a |
15 | CTCF | chr17:16719240-16719390 | HCT-116 | colon: | n/a | n/a |
16 | CTCF | chr17:16719360-16719510 | NHEK | skin: | n/a | n/a |
17 | CTCF | chr17:16720520-16720577 | GM12892 | blood: | n/a | n/a |
18 | CTCF | chr17:16719220-16719370 | HMEC | breast: | n/a | n/a |
19 | CTCF | chr17:16719921-16719989 | GM13976 | blood: | n/a | n/a |
20 | CTCF | chr17:16719200-16719350 | HEEpiC | esophagus: | n/a | n/a |
21 | FOS | chr17:16719328-16719385 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOSL2 | chr17:16719261-16719478 | HepG2 | liver: | n/a | n/a |
23 | FOXA1 | chr17:16715538-16715748 | T-47D | breast: | n/a | n/a |
24 | HCFC1 | chr17:16715633-16715667 | K562 | blood: | n/a | n/a |
25 | IRF4 | chr17:16710910-16711331 | GM12878 | blood: | n/a | n/a |
26 | IRF4 | chr17:16710955-16711450 | GM12878 | blood: | n/a | n/a |
27 | MAFF | chr17:16719174-16719440 | K562 | blood: | n/a | n/a |
28 | MAFK | chr17:16719241-16719455 | K562 | blood: | n/a | n/a |
29 | MAX | chr17:16715518-16715782 | K562 | blood: | n/a | n/a |
30 | MAX | chr17:16715522-16715744 | K562 | blood: | n/a | n/a |
31 | MAX | chr17:16715516-16715802 | K562 | blood: | n/a | n/a |
32 | MAX | chr17:16715638-16715647 | Hela-S3 | cervix: | n/a | n/a |
33 | MXI1 | chr17:16715695-16715720 | Hela-S3 | cervix: | n/a | n/a |
34 | MYC | chr17:16715621-16715653 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | PAX5 | chr17:16710882-16711316 | GM12878 | blood: | n/a | n/a |
36 | POU2F2 | chr17:16710946-16711361 | GM12878 | blood: | n/a | n/a |
37 | RCOR1 | chr17:16715518-16715718 | K562 | blood: | n/a | n/a |
38 | REST | chr17:16715455-16715867 | K562 | blood: | n/a | n/a |
39 | REST | chr17:16715296-16716094 | U87 | brain: | n/a | n/a |
40 | REST | chr17:16715387-16715872 | Hela-S3 | cervix: | n/a | n/a |
41 | REST | chr17:16715473-16715800 | K562 | blood: | n/a | n/a |
42 | REST | chr17:16715385-16715946 | PFSK-1 | brain: | n/a | n/a |
43 | REST | chr17:16715516-16715695 | GM12878 | blood: | n/a | n/a |
44 | REST | chr17:16715435-16715784 | SK-N-SH | brain: | n/a | n/a |
45 | REST | chr17:16715509-16715764 | HepG2 | liver: | n/a | n/a |
46 | REST | chr17:16715453-16715865 | A549 | lung: | n/a | n/a |
47 | REST | chr17:16715432-16715978 | GM12878 | blood: | n/a | n/a |
48 | REST | chr17:16715327-16715906 | SK-N-SH | brain: | n/a | n/a |
49 | REST | chr17:16715410-16715769 | HepG2 | liver: | n/a | n/a |
50 | REST | chr17:16715368-16715933 | U87 | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264892 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56280749 | chr17:16710840-16710841 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554699043 | chr17:16710868-16710869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568328331 | chr17:16710921-16710922 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs537717130 | chr17:16710963-16710964 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs557392638 | chr17:16710966-16710967 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs577495009 | chr17:16711068-16711069 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs545466055 | chr17:16711076-16711077 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs145818769 | chr17:16711122-16711123 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs565567070 | chr17:16711131-16711132 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs528071278 | chr17:16711168-16711169 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs111755303 | chr17:16711215-16711216 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572970685 | chr17:16711247-16711248 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs111694558 | chr17:16711305-16711306 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs541948361 | chr17:16711328-16711329 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs561823105 | chr17:16711363-16711364 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs183259384 | chr17:16711374-16711375 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs542101236 | chr17:16711378-16711379 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs530633350 | chr17:16711392-16711393 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs544464490 | chr17:16711423-16711424 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs564201660 | chr17:16711436-16711437 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs3869512 | chr17:16711477-16711478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188140519 | chr17:16711478-16711479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552141101 | chr17:16711488-16711489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557303980 | chr17:16711539-16711540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112231066 | chr17:16711542-16711543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113355537 | chr17:16711571-16711572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548293307 | chr17:16711573-16711574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568288655 | chr17:16711586-16711587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190967505 | chr17:16711666-16711667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141221135 | chr17:16711704-16711705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113735856 | chr17:16711712-16711713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182282888 | chr17:16711727-16711728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112269140 | chr17:16711734-16711735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540172877 | chr17:16711756-16711757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552956884 | chr17:16711774-16711775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371872271 | chr17:16713854-16713855 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs142886470 | chr17:16713864-16713865 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs533587667 | chr17:16713876-16713877 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs375198644 | chr17:16713882-16713883 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs568846666 | chr17:16714137-16714138 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs537512247 | chr17:16714154-16714155 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs199774728 | chr17:16714161-16714162 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs557858065 | chr17:16714169-16714170 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs375443177 | chr17:16714184-16714185 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs633834 | chr17:16714208-16714209 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs188656276 | chr17:16714222-16714223 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs2448620 | chr17:16714227-16714228 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs553593122 | chr17:16714241-16714242 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs2621720 | chr17:16714246-16714247 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs2448619 | chr17:16714247-16714248 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastric cancer | 18160780 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21509527 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:16689600-16711600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr17:16698000-16711800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
3 | chr17:16711600-16711800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr17:16716600-16723200 | Weak transcription | Right Atrium | heart |
5 | chr17:16717200-16720000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr17:16717400-16717600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr17:16717400-16717800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr17:16717600-16717800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr17:16717600-16718000 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
10 | chr17:16717600-16718200 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
11 | chr17:16717600-16718200 | Enhancers | Right Ventricle | heart |
12 | chr17:16717600-16718200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr17:16717800-16719000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr17:16718000-16719000 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
15 | chr17:16718000-16719000 | ZNF genes & repeats | Spleen | Spleen |
16 | chr17:16718600-16719200 | Enhancers | A549 | lung |
17 | chr17:16718600-16720600 | Weak transcription | Placenta Amnion | Placenta Amnion |
18 | chr17:16719000-16719200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr17:16719000-16719200 | Enhancers | NHEK | skin |
20 | chr17:16719000-16719400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr17:16719000-16723200 | Weak transcription | Spleen | Spleen |
22 | chr17:16719000-16724000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr17:16719200-16720600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
24 | chr17:16719200-16723600 | Weak transcription | NHEK | skin |
25 | chr17:16719400-16720200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
26 | chr17:16720200-16722400 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
27 | chr17:16720600-16722200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
28 | chr17:16720600-16723000 | Strong transcription | Placenta Amnion | Placenta Amnion |
29 | chr17:16720600-16723200 | Strong transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |